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Abstract
A general system has been devised for the in vivo construction of Candida albicans
integrative vectors in Saccharomyces cerevisiae. The system is especially useful for
the integration of genes in C. albicans that cannot be propagated in Escherichia coli,
possibly because of their toxic effects. The ligation of S. cerevisiae 2 µ sequences
to a C. albicans integrative vector permits in vivo maintenance and gap repair
cloning within S. cerevisiae. After the vector assembly, it can be purified from
S. cerevisiae or amplified by PCR and then used for transformation of C. albicans. The
S. cerevisiae 2 µ sequence is completely removed by linearization prior to C. albicans
transformation, such that no unwanted DNA is transferred in the final construct.
The system was successfully used to clone and reintegrate the C. albicans JEN2
gene, which encodes a membrane protein that is apparently toxic to E. coli. Three
popular C. albicans integrative vectors, CIp10, CIp20 and CIp30, are now available in
versions that permit gap repair in S. cerevisiae. GenBank Accession Nos CIp10–2 µ
(GU550119), CIp20–2 µ (GU550120) and CIp30–2 µ (GU550121). Copyright  2010
John Wiley & Sons, Ltd.
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Introduction
Candida albicans is a major fungal pathogen
especially for patients with compromised immune
systems (Odds, 1988). Many of the molecular tools
that have been developed for this organism are
essentially based on those for the distantly related
Saccharomyces cerevisiae. However, since C. albi-
cans is an obligate diploid, gene disruptions must
be carried out twice to inactivate both alleles for
each gene (Berman and Sudbery, 2002; Noble and
Johnson, 2007). Autonomously replicating plas-
mids exist for C. albicans (Cannon et al., 1992) but
their use is limited, since they are less stable than
their S. cerevisiae counterparts. The construction of
expression plasmids for C. albicans is most often
achieved by cloning the gene of interest into these
plasmids using Escherichia coli before integrating
them into the C. albicans genome by homologous
recombination (Sonneborn et al., 2000; Tripathi
et al., 2002).
In C. albicans, the position of marker genes (such
as URA3 ) may substantially affect the expres-
sion level of the marker gene (Lay et al., 1998)
and, more importantly, virulence in animal mod-
els of candidiasis (Sundstro¨m et al., 2002). Fur-
ther research has shown that integration of the
URA3 in the RPS1 locus leads to expression lev-
els that can restore virulence levels comparable
to that of URA3 at its wild-type locus (Brand
et al., 2004). A series of vectors has been devel-
oped for integrating sequences at the RPS1 locus
(Dennison et al., 2005; Murad et al., 2000) to pre-
vent URA3 expression levels from influencing the
virulence of these transformants. Since the effect
of marker expression level on virulence is likely
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Table 1. S. cerevisiae, E. coli and C. albicans strains used in this study
Strain Genotype Reference
S. cerevisiae
CEN.PK 113-5D MATa ura3 van Dijken et al., 2000
E. coli
XL1BLUE endA1 gyrA96(nalR) thi-1 recA1 relA1 lac
glnV44 F′[::Tn10 proAB+ lacIq ∆(lacZ)M15]
hsdR17(rK− mK+)
Bullock, 1987
C. albicans
RM1000 ura3::imm434/ura3::imm434,
his1::hisG/his1::hisG
Negredo et al., 1997
CNV3 ura3::imm434/ura3::imm434,his1::hisG/his1::G
jen2::HIS1/jen2::URA3
Vieira et al., 2009
CNV3-1 CNV3 with RPS1– CIp20 Vieira et al., 2009
CNF5 CNV3 with RPS1– CIp20– JEN2 This study
to be complex, the same vector integrated at the
same genetic locus should be used for comparisons
across genetic modifications if virulence is to be
measured.
The use of this system to overcome these posi-
tional effects of marker genes creates an implicit
need to assemble genetic constructions in E. coli.
However, this creates a problem if the C. albi-
cans genetic modification cannot be propagated in
this organism. Genes encoding eukaryotic mem-
brane proteins are sometimes toxic to the extent
that cloning is not possible in E. coli. Exam-
ples of these include S. cerevisiae hexose trans-
porters HXT15 and HXT16 (Wieczorke et al.,
1999) and the C. albicans JEN2 (Vieira et al.,
2009).
In S. cerevisiae, this can be overcome by direct
cloning in yeast by in vivo gap repair. Orr-Weaver
and Szostak (1983) were the first to report in vivo
gap repair of two linear fragments into an episo-
mal plasmid. This method has been widely used
for direct high-throughput cloning of genes and
libraries in yeast, where omitting E. coli in the
cloning step simplifies the procedure and may
increase the coverage of libraries. Therefore, we
have created a set of three integrative C. albicans
vectors, CIp10–2 µ, CIp20–2 µ and CIp30–2 µ,
which permit in vivo assembly in S. cerevisiae.
These vectors are based on the popular C. albicans
integrative vectors CIp10 (Murad et al., 2000),
CIp20 and CIp30 (Dennison et al., 2005). These
vectors have one, two or three nutritional markers,
respectively, for complementation of auxotrophic
mutations (URA3, HIS1, ARG4 ), and they con-
tain the C. albicans RPS1 gene, which is used to
direct integration of the plasmid to this genomic
locus.
The CIp20–2 µ vector was used to clone the
C. albicans JEN2 gene in S. cerevisiae using
gap repair, resulting in CIp20–2 µ–JEN2. Despite
many attempts and the use of a range of alterna-
tive cloning strategies, we were unable to clone
JEN2 in E. coli. We tried unsuccessfully an E.
coli strain that maintains a low copy number of
the vector (CopyCutter EPI400, EPICENTRE
Biotechnologies, Madison, WI, USA), as well as
constructing the vector by fusion PCR to avoid
the E. coli cloning step. However, we were able
to make CIp20–2 µ–JEN2 in S. cerevisiae and
the JEN2 gene did not show any adverse effects
in the yeast transformants. The cloned JEN2 was
then reintegrated in the RPS1 genomic locus of
a C. albicans jen2 knockout mutant (Vieira et al.,
2009). The JEN2 reintegration, which was con-
firmed by diagnostic PCR, suppressed the pheno-
types of the C. albicans jen2 knockout mutant.
Growth on a medium containing succinic acid as
sole carbon and energy source, as well as the ability
to transport radiolabelled succinic acid by a medi-
ated mechanism, was restored.
Materials and methods
Yeast strains, plasmids and growth conditions
Yeast strains and the plasmids used in this work
are listed in Tables 1 and 2, respectively. Strains
were maintained on solid YPD medium (Sherman,
1991). Growth of C. albicans strains was per-
formed at 30 ◦C in synthetic complete (SC) medium
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Table 2. Plasmids used in this study
Plasmids Source or reference
CIp20 Dennison et al., 2005
CIp20–2 µ– JEN2 This work
YEplac112 Gietz and Sugino, 1988
without uracil or histidine (2% w/v glucose, 0.67%
w/v yeast nitrogen base without amino acids and
2 g/l complete amino acid mixture without histi-
dine or uracil; Kaiser, 1994). The same medium
was also prepared with succinic acid (1% v/v, pH
5.0) as carbon source. Growth of S. cerevisiae was
performed in synthetic defined (SD) medium with
the same composition but leaving out the amino
acid mixture. Solid media were prepared by adding
agar (2% w/v).
Transport assays
Yeast cells were grown in SC medium to obtain
glucose repressed cells. For conditions of glu-
cose derepression, cells grown in SC medium
were washed twice in ice-cold deionized water
and inoculated into fresh SC medium with suc-
cinic acid instead of glucose. Cells were har-
vested during the exponential phase (OD640 nm =
0.5) by centrifugation, washed twice and resus-
pended in ice-cold deionized water to a final con-
centration of 25–35 mg dry weight/ml. Uptake
rates of labelled succinic acid [(2,3-14C) succinic
acid (NEN Life Science); 5000 dpm/nM, pH 5.0]
were estimated as described by Vieira et al. (2009).
A computer-assisted non-linear regression analy-
sis program (GraphPad Software, San Diego, CA,
USA) was used in order to determine the best-
fitting transport kinetics to the experimental data
and to estimate the kinetic parameters. All the
experiments were performed in biological tripli-
cates and the data presented represent average val-
ues, with error bars corresponding to the standard
deviation (SD).
Construction of the CIpX0–2 µ vectors
CIp10, CIp20 and CIp30 were digested with
StuI (AGG CCT), a restriction enzyme produc-
ing blunt ends that is normally used to linearize
the vector before integration. The linearized vec-
tors were ligated in vitro to a blunt PCR product
Table 3. Oligonucleotides used in this study
Name Sequence
2 µ-CENARS AarI f CCT TTG CAG GTG GTA TTT
CAC ACC GCA TAT ATC G
2 µ-CENARS AarI r CCT TTG CAG GTG TTT TGA
AAA GCA AGC ATA AAA GAT
C
cip20 3551 fwd TTT TCA ATT TCA CGG CCA
AT
2my 4936 fwd GCA CAG AGA TAT ATA GCA
AAG AGA TAC
cip20 5676 rev CAA CAG ATC TAC CGG TTT
AAA GAA
2my 4057 rev GAA CCG GGG ATG CGA CGT
CaJEN2 rv lo AAA GGG AAC AAA AGC TGG
GTA CCG GGC CCC CCC TCG
AGG TCG ACC CGT CTC ATA
TTT CTA ACC GAT TGT GCC
AGT GGC TC
CaJEN2 fw sh CTT GTT TTT ACC GAC AGC
CAT GTT GTA CTT GAG TTG
GAT CTA CGC GTG AGC ACT
AAC AAT TAG TTG TAC AGT
TCA AA ACT
CaJEN2A1fwd GGT GAT ACA TAT GGT AGA
CaJEN2A2rev GTG ATC CAC ATT GGA TGG
DRPS10fwd GTG GTT GGA GCT TTG ATG
DCaJEN2Rev AGC CAT GAG AGC CAT CTC
HIS1 fw TCA TCC TCC AGG TAC CGG
ATC
RPS10 5ORF fwd ACT TTG ATC AAC AGA TCT
AC
of the S. cerevisiae 2 µ replication origin, con-
taining one half StuI site at each end. The PCR
product was amplified from the vector YEplac112
(Gietz and Sugino, 1988) with the primers 2 µ-
CENARS AarI f and 2 µ-CENARS AarI r (Table
3). Although many vectors carry the 2 µ sequence,
the one in YEplac112 lacks a XbaI site due to
directed mutagenesis, making this site available
for manipulation elsewhere in the resulting vec-
tor. The ligation mixture was transformed directly
to S. cerevisiae CEN.PK113-5D (ura3-52), using
the high efficiency LiAc/ssDNA protocol (Gietz
and Schiestl, 2007). Transformants were selected
on solid SD medium on the rationale that the C.
albicans URA3 gene is able to complement the
S. cerevisiae ura3 mutation. Transformants were
found to be almost exclusively the correct plasmids,
which was as expected, since none of the DNA
fragments alone should be able to both propagate in
S. cerevisiae and complement the ura3 mutation.
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Figure 1. Schematic representation of the in vivo construction of CIp20–2 µ–JEN2 in S. cerevisiae. Only CIp20–2 µ is
shown in this schematic overview but the methodology is similar for the CIp10–2 µ and CIp30–2 µ construction. CIp20
was initially digested with StuI and ligated to the 2 µ sequence from YEplac112 in vitro. The CIp20–2 µ vector was isolated
from yeast and amplified in E. coli. CIp20–2 µ was then digested with MluI and SalI and co-transformed with a PCR-amplified
JEN2 fragment into S. cerevisiae. Transformants were selected for uracil prototrophy. The circular vector was purified and
used as template for PCR amplification. Finally, StuI digestion enabled the integration of the CIp20–2 µ plasmids at the
RPS1 genomic locus. The image was made with the vector drawing software Simvector from Premier Biosoft International
(http://www.premierbiosoft.com/plasmid maps/index.html)
The vectors were rescued from yeast by a com-
bination of glass beads and E. coli plasmid mini
preparation columns and transformed to E. coli.
The vectors were purified from E. coli and anal-
ysed by digestion with StuI to confirm the release
of the 2 µ sequence. The location and orientation of
the 2 µ sequence was confirmed by PCR, using the
primer pairs cip20 3551 fwd/2my 4507 rev and
cip20 4936 fwd/2my 5676 rev, producing PCR
products of 764 bp and 525 bp across the vec-
tor insert junctions, respectively. The vectors
were given the names CIp10–2 µ, CIp20–2 µ and
CIp30–2 µ (Figure 1). The sequences are available
from GenBank under AccessionNos GU550 119,
GU550 120 and GU550 121, respectively.
Construction of the CIp20–2 µ–JEN2 vector
The CIp20–2 µ vector was digested with MluI and
Sal I in the presence of shrimp alkaline phosphatase
to prevent religation of the vector. The enzymes
were heat-inactivated according to the manufac-
turer’s instructions. A 4295 bp fragment containing
the C. albicans JEN2 locus was PCR-amplified
from C. albicans genomic DNA, using the primers
CaJEN2 rv lo and CaJEN2 fw sh (Table 3). The
primers add 41 and 45 bp of homology to the
CIp20–2 µ vector, up- and downstream of the MluI
and Sal I sites. The linear vector and the PCR
product were co-transformed into S. cerevisiae
CEN.PK113-5D (ura3-52) and transformants were
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selected for uracil prototrophy on SD medium.
The presence of the C. albicans JEN2 gene
sequence in the transformants was confirmed by
colony PCR, using the primers CaJEN2A1fwd and
CaJEN2A2rev (Table 3), which amplify a 764 bp
PCR product internally in the JEN2 locus. The cor-
rect location of the JEN2 relative to the CIp20–2 µ
vector was confirmed by PCR with the DRPS10fwd
and DCaJEN2Rev primers (Table 3), resulting in a
387 bp PCR product across the junction between
the RPS1 gene of the vector and the JEN2 frag-
ment.
Isolation of the CIp20–2 µ–CaJEN2 vector
from S. cerevisiae
Several protocols have been described for the iso-
lation of plasmids from S. cerevisiae. Most proto-
cols rely on transformation of E. coli of a crude
yeast DNA preparation. Since it was not possible
to propagate the JEN2 gene, a method was needed
for direct isolation of plasmid DNA from yeast.
S. cerevisiae has a strong cell wall and expresses
more nuclease activities than the normally used lab-
oratory strains of E. coli, so direct plasmid purifica-
tion poses a technical problem. Direct isolation of
plasmid DNA and separation of circular and linear
DNA has been described using CsCl density gra-
dient centrifugation, alkaline lysis of spheroplasts
and partitioning of linear DNA using acid phenol.
In our hands it was difficult to prepare DNA of
sufficient quantity and quality using these meth-
ods. We therefore chose to use a combination of
plasmid DNA preparation from S. cerevisiae and
amplification of the vector using long PCR. We pre-
pared a small quantity of plasmid DNA from the
S. cerevisiae strain, using the same protocol com-
bining glass beads and plasmid mini-preparation
columns described earlier. We used 4% v/v of
the isolated DNA as template for PCR, using the
Long PCR Enzyme Mix (FERMENTAS) accord-
ing to the manufacturer’s recommendations and the
primers 2my 4936 fwd and 2my 4057 rev. Four
50 µl PCR reaction were pooled, purified using the
SureClean DNA cleanup kit (BIOLINE) and resus-
pended in 50 µl TE buffer. The PCR product was
then digested with StuI by adding 7.4 µl buffer
2.5 µl StuI to 17.1 µl concentrated PCR product
and used to transform C. albicans (Walther and
Wendland, 2003). Three independent transformants
were obtained and the correct localization of the
CIp20–JEN2 vector was confirmed by PCR, using
primers HIS1 fw and RPS10 5ORF fwd (Table 3).
The first primer is plasmid-specific, whereas the
second is located in the genomic RPS1 locus, pro-
ducing a PCR product of 672 bp from the correct
integrated plasmid (Figure 2).
Results and discussion
We have constructed a series of C. albicans
integrative vectors (CIp10–2 µ, CIp20–2 µ and
CIp30–2 µ) that permit plasmid construction
in vivo by gap repair in S. cerevisiae. The vectors
were constructed by combining a series of widely
used C. albicans vectors (CIp10, −20 and −30)
and a PCR product of the yeast 2 µ sequence. This
sequence was inserted within the part of the vector
that normally directs the chromosomal integration
to a specific locus by ends-in homologous recom-
bination. The enzyme used to linearize the vector
before transformation in C. albicans was retained
on each side of the 2 µ sequence, so that it is lost
by linearization of the vector. This means that no
Figure 2. Verification of JEN2 ligation to CIp20–2 µ
and of plasmid integration in the RPS1 genomic
locus by analytical PCR. Correct recombination of
JEN2 in CIp20–2 µ was confirmed by diagnostic PCR
with primers CaJEN2A1fwd/CaJEN2A2rev (764 bp) and
DRPS10fwd/DCaJEN2Rev (387 bp), as represented in lanes
2 and 3, respectively. Additionally, correct integration of
the CIp20–JEN2 in the RPS1 genomic locus was confirmed
with primers HIS1 fw/RPS10 5ORF (672bp) fwd and is rep-
resented in lane 4
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Figure 3. Growth phenotypes and transport of succinic acid in C. albicans jen2 mutants. RM1000 (wild-type), CNV3 (jen2)
and the reintegrant CNF5 (jen2, RPS1–CIp20–JEN2). (A) C. albicans strains were incubated for 48 h at 37 ◦C in the following
solid media: SC Glu (2%, w/v) and SC succinic acid (1%, w/v, pH 5.0). Cells were serially diluted and 5 µl drops of each
dilution were spotted onto the plates: Wt, C. albicans RM1000 (JEN2/JEN2); jen2 + CIp20, CNV3 (jen2/jen2, RPS1–CIp20);
jen2 + CIp20–JEN2, CNF5 (jen2/jen2, RPS1–CIp20–JEN2). (B) Initial uptake rates of (2,3-14C) succinic acid at pH 5.0, as a
function of succinic acid concentration after growth in medium containing succinic acid. ž, C. albicans RM1000 (JEN2/JEN2);
, CNV3 (jen2/jen2); , CNF5 (jen2/jen2, RPS1–CIp20–JEN2). Error bars represent SD of experiments carried out in
biological triplicates
S. cerevisiae sequences are transferred to C. albi-
cans and the resulting integrated construct is not
affected by the strategy. These vectors facilitate the
cloning and integration of genes that are toxic in
E. coli in C. albicans. A schematic view of the
strategy is shown in Figure 1.
The gene JEN2 encodes a C. albicans dicar-
boxylate transporter, the deletion of which from
C. albicans impairs the mediated transport of suc-
cinic and malic acid and leads to a growth defect
on these substrates (Vieira et al., 2009). We have
previously tried unsuccessfully to clone this gene
in E. coli by ligating a JEN2 PCR product into
a linearized CIp20 vector (Vieira et al., 2009).
Exhaustive attempts to clone JEN2 in E. coli using
alternative strategies were also unsuccessful in our
hands (unpublished). In the current study we ampli-
fied the same JEN2 fragment with primers adding
a short stretch of homology to each side of the
cloning site in CIp20–2 µ. The CIp20–2 µ and the
PCR product were assembled in vivo and given the
name CIp20–2 µ–JEN2. CIp20–2 µ–JEN2 was
amplified by long PCR from S. cerevisiae, digested
and integrated in a C. albicans jen2/jen2 double
mutant, as described in Materials and methods. The
correct integration was confirmed by colony PCR
(Figure 2).
The growth phenotypes of C. albicans RM1000
(wild-type), CNV3 (jen2/jen2 ) and the reintegrant
CNF5 (jen2/jen2, RPS1–CIp20 –JEN2) were eval-
uated on both SC glucose 2% and SC succinic
acid 1% solid media. No growth defect was found
in SC glucose medium (Figure 3A, left panel),
as expected. A growth defect was observed on
succinic acid for jen2/jen2 cells, and the inser-
tion of CIp20–2 µ–JEN2 fully restored the ability
to grow on this carbon source (Figure 3A, right
panel). In addition, we measured initial uptake
rates of labelled succinic acid, pH 5.0, in cells
grown on succinic acid. Like wild-type JEN2/JEN2
cells, the jen2/jen2/JEN2 strain displayed the abil-
ity to transport succinate by a mediated mech-
anism, indicating that the reintegration of JEN2
had suppressed this phenotype of the jen2/jen2
mutant.
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This in vivo gap repair strategy is not limited to
the three vectors described here but can, in prin-
ciple, be applied to any integrative C. albicans
vectors, provided that the enzyme used to linearize
the vector is added to each side of the 2 µ sequence
before ligation to the vector. The plasmid isolation
of the assembled vectors by PCR from S. cere-
visiae could be done more efficiently using primers
annealing immediately up- and downstream of
the 2 µ sequences, so that the PCR product is
devoid of S. cerevisiae sequences and no subse-
quent digestion is necessary. We chose to use the
2my 4936 fwd and 2my 4057 rev primers, which
meant that the extraneous S. cerevisiae sequences
had to be removed by StuI digestion, since this
avoided the synthesis of new oligonucleotides. This
novel strategy, which has proved to be a very use-
ful tool for the construction of an integrative vector
of a toxic gene, can be used for the reintegration
of any gene in C. albicans.
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